FDA reform: incremental approach urged by Rep. Fox in a Dec. 22 letter.
This article was originally published in The Rose Sheet
FDA REFORM SHOULD FOCUS ON CONSENSUS ISSUES FIRST, REP. FOX urged in a recent letter to the House Republican leadership. Congress "should move immediately to develop a bipartisan consensus on those [FDA reform] changes that we can make to ease current regulatory requirements," according to the Dec. 22 letter drafted by Rep. Jon Fox (R-PA) and signed by nearly all members of the Pennsylvania House delegation. The letter was sent to Speaker Newt Gingrich (R-GA), Commerce Committee Chairman Thomas Bliley (R-VA) and Commerce/Health & Environment Subcommittee Chairman Michael Bilirakis (R-FL).
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review